Insulin releasing and alpha-glucosidase inhibitory activity of ethyl acetate fraction of Acorus calamus in vitro and in vivo

Journal of Ethnopharmacology

Volumn 128, Issue 1, 2010, Pages 154-159

  Si, Mei mei ^a   Lou, Jian shu ^a   Zhou, Chang Xin ^b   Shen, Juan Na ^a   Wu, Hong Hai ^a   Yang, Bo ^a   He, Qiao Jun ^a   Wu, Hao Shu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Acorus calamus L.; Alpha glucosidase; Diabetes; Insulin releasing; Postprandial hyperglycemia

Indexed keywords

ACARBOSE; ACETIC ACID ETHYL ESTER; ACORUS CALAMUS EXTRACT; ALPHA GLUCOSIDASE; GLICLAZIDE; GLUCOSE; INSULIN; STARCH;

ACORUS CALAMUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; IC 50; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; INSULIN RELEASE; MALE; MOUSE; NONHUMAN;

ACETATES; ACORUS; ALPHA-GLUCOSIDASES; ANIMALS; BLOOD GLUCOSE; CELL LINE; ENZYME INHIBITORS; INSULIN; KINETICS; MALE; MICE; MICE, INBRED ICR; POSTPRANDIAL PERIOD;

ACORUS CALAMUS; MUS;

EID: 76749142045     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.044     Document Type: Article

References (31)

1. Al-Salman J., Arjomand H., Kemp D.G., Mittal M. Hepatocellular injury in a patient receiving rosiglitazone. A case report. Annals Internal Medicine 2000, 132:121-124.
2. Bailey C.J., Day C. Traditional plant medicines as treatments for diabetes. Diabetes Care 1989, 12:553-564.
3. Balfour J.A., McTavish D. Acarbose. An update of its pharmacology and therapeutic use in diabetes mellitus. Drugs 1993, 46:1025-1054.
4. Baron A.D. Postprandial hyperglycemia and alpha-glucosidase inhibitors. Diabetes Research and Clinical Practice 1998, 40:S51-S55.
5. Ceriello A., Taboga C., Tonutti L., Quagliaro L., Piconi L., Bais B., Da Ros R., Motz E. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002, 106:1211-1218.
6. Cesspooch, L., 2005. Native American Traditional Medicine and Diabetes: Acorus calamus L. A sacred Medicinal Plant of the Native Cree. http://hlunix.hl.state.ut.us/diabetes/telehealth/2005archives.htm.
7. Davis S.N., Granner D.K. Oral hypoglycemic agents. Goodman and Gilman's the Pharmacological Basis of Therapeutics 2001, 1701-1707. 10th ed.
8. Dennehy C.E., Tsourounis C., Miller A.E. Evaluation of herbal dietary supplements marketed on the internet for recreational use. The Annals of Pharmacotherapy 2005, 39:1634-1639.
9. Forman L.M., Simmons D.A., Diamond R.H. Hepatic failure in a patient taking rosiglitazone. Annals of Internal Medicine 2000, 132:118-121.
10. Hu S., Wang S., Fanelli B., Bell P.A., Dunning B.E., Geisse S., Schmitz R., Boettcher B.R. Pancreatic, beta-cell K (ATP) channel activity and membrane-binding studies with nateglinide: a comparison with sulfonylureas and repaglinide. The Journal of Pharmacology and Experimental Therapeutics 2000, 293:444-452.
11. Keilson L., Mather S., Walter Y.H., Subramanian S., McLeod J.F. Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology & Metabolism 2000, 85:1081-1086.
12. Lebovitz H.E. Effect of the postprandial state on nontraditional risk factors. The American Journal of Cardiology 2001, 88:20H-25H.
13. Lebovitz H.E. Postprandial hyperglycaemic state: importance and consequences. Diabetes Research and Clinical Practice 1998, 40(Suppl.):S27-S28.
14. Li Y., Wen S., Kota B.P., Peng G., Li G.Q., Yamahara J., Roufogalis B.D. Punica granatum flower extract, a potent alpha-glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology 2005, 99:239-244.
15. Maeda K. Hepatocellular injury in a patient receiving pioglitazone. Annals of Internal Medicine 2001, 135:306.
16. May L.D., Lefkowitch J.H., Kram M.T., Rubin D.E. Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy. Annals of Internal Medicine 2002, 136:449-452.
17. Mukherjee P.K., Kumar V., Mal M., Houghton P.J. In vitro acetylcholinesterase inhibitory activity of the essential oil from Acorus calamus and its main constituents. Planta Medica 2007, 73:283-285.
18. Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. The New England Journal of Medicine 2007, 356:2457-2471.
19. Ortiz-Andrade R.R., García-Jiménez S., Castillo-España P., Ramírez-Avila G., Villalobos-Molina R., Estrada-Soto S. α-Glucosidase inhibitory activity of the methanolic extract from Tournefortia hartwegiana: an anti-hyperglycemic agent. Journal of Ethnopharmacology 2007, 109:48-53.
20. Parab R.S., Mengi S.A. Hypolipidemic activity of Acorus calamus L. in rats. Fitoterapia 2002, 73:451-455.
21. Ravinuthala R.S., Nori U. Rosiglitazone toxicity. Annals of Internal Medicine 2000, 133:658. Letter.
22. Rosak C. The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents. Journal of Diabetes and its Complications 2002, 16:123-132.
23. Seufert J., Lübben G., Dietrich K., Bates P.C. A comparison of the effects of thiazolidinediones and metformin on metabolic control in patients with type 2 diabetes mellitus. Clinical Therapeutics 2004, 26:805-818.
24. Shim Y.J., Doo H.K., Ahn S.Y., Kim Y.S., Seong J.K., Park I.S., Min B.H. Inhibitory effect of aqueous extract from the gall of Rhus chinensis on alpha-glucosidase activity and postprandial blood glucose. Journal of Ethnopharmacology 2003, 85:283-287.
25. Shukla P.K., Khanna V.K., Ali M.M., Maurya R.R., Handa S.S., Srimal R.C. Protective effect of Acorus calamus against acrylamide induced neurotoxicity. Phytotherapy Research 2002, 16:256-260.
26. Shukla P.K., Khanna V.K., Ali M.M., Maurya R., Khan M.Y., Srimal R.C. Neuroprotective effect of Acorus calamus against middle cerebral artery occlusion-induced ischaemia in rat. Human Experimental Toxicology 2006, 25:187-194.
27. Spiller H.A., Sawyer T.S. Toxicology of oral antidiabetic medications. American Journal of Health-System Pharmacy 2006, 63:929-938.
28. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., Hadden D., Turner R.C., Holman R.R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal 2000, 321:405-412.
29. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
30. Wu H.S., Li Y.Y., Weng L.J., Zhou C.X., He Q.J., Lou Y.J. A fraction of Acorus calamus L. extract devoid of beta-asarone enhances adipocyte differentiation in 3T3-L1 cells. Phytotherapy Research 2007, 21:562-564.
31. Wu H.S., Zhu D.F., Zhou C.X., Feng C.R., Lou Y.J., Yang B., He Q.J. Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo. Journal of Ethnopharmacology 2009, 123:288-292.